AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8061853 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril 12 mg/day
Number of subjects: 260
Study 8061853 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril 24 mg/day
Number of subjects: 260
Study 8061853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 8061853 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril (all dosages)
Number of subjects: 260
Study 3058383 — intervention group
Group type: EXPERIMENTAL
Intervention: Norinyl 1/35
Number of subjects: 300
Study 3058383 — intervention group
Group type: COMPARATOR
Intervention: Brevicon
Number of subjects: 300
Study 31680625 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Stress Management
Number of subjects: 92
Study 31680625 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 92
Study 30099030 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide treatment for 12 weeks
Number of subjects: 0
Study 30099030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28891873 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapedotomy with fixation of the incus‐prosthesis junction with glass ionomer bone cement (Group B)
Number of subjects: 80
Study 28891873 — intervention group
Group type: COMPARATOR
Intervention: Stapedotomy with the classic technique (Group A)
Number of subjects: 80
Study 25887046 — intervention group
Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 350
Study 25887046 — intervention group
Group type: COMPARATOR
Intervention: Spinal manipulation
Number of subjects: 350
Study 24006669 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group received acupuncture stimulation at various acupoints (Baihui, Neiguan, Sanyinjiao, Taichong, etc.) once daily, 5 times a week for 20 times.
Number of subjects: 63
Study 24006669 — intervention group
Group type: EXPERIMENTAL
Intervention: Catgut embedding group received catgut embedding at the same acupoints as the acupuncture group, once every 10 days, 3 times altogether.
Number of subjects: 63
Study 21869695 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg for 2 weeks
Number of subjects: 20
Study 21869695 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 20
Study 19153649 — intervention group
Group type: COMPARATOR
Intervention: Tau protein levels in AD patients
Number of subjects: 69
Study 19153649 — intervention group
Group type: COMPARATOR
Intervention: Index tau/beta-amyloid(1-42) levels in AD patients
Number of subjects: 69
Study 19153649 — intervention group
Group type: COMPARATOR
Intervention: Cystatin C values
Number of subjects: 69
Study 19153649 — intervention group
Group type: COMPARATOR
Intervention: CSF cystatin C
Number of subjects: 69
Study 19153649 — intervention group
Group type: COMPARATOR
Intervention: CSF tau protein
Number of subjects: 69
Study 16384626 — intervention group
Group type: COMPARATOR
Intervention: -842C allele carriers in AD subjects
Number of subjects: 111
Study 16384626 — intervention group
Group type: EXPERIMENTAL
Intervention: -842C allele
Number of subjects: 111
Study 16384626 — intervention group
Group type: EXPERIMENTAL
Intervention: CC haplotype
Number of subjects: 111
Study 16384626 — intervention group
Group type: EXPERIMENTAL
Intervention: -842 CC genotype or CC haplotype
Number of subjects: 111
Study 15325930 — intervention group
Group type: EXPERIMENTAL
Intervention: Overt hyperthyroidism
Number of subjects: 259
Study 15325930 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism (during antithyroid therapy)
Number of subjects: 259
Study 15325930 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical euthyroidism
Number of subjects: 259
Study 15325930 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithyroid treatment
Number of subjects: 259
Study 15325930 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects with euthyroidism
Number of subjects: 259
Study 15240983 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg effervescent acetylsalicylic acid (ASA)
Number of subjects: 433
Study 15240983 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg encapsulated sumatriptan
Number of subjects: 433
Study 15240983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433
Study 10987048 — intervention group
Group type: EXPERIMENTAL
Intervention: Medico-surgical treatment (including nerve surgical decompression)
Number of subjects: 31
Study 10987048 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (steroids only)
Number of subjects: 31
Study 7743399 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-air-loss beds
Number of subjects: 84
Study 7743399 — intervention group
Group type: COMPARATOR
Intervention: Conventional foam mattresses
Number of subjects: 84
Study 2073120 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg daily for 14 days)
Number of subjects: 39
Study 2073120 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole troches (10 mg each, five troches daily for 14 days)
Number of subjects: 39
Study 7027714 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose followed 60 min later by iv glipizide
Number of subjects: 6
Study 7027714 — intervention group
Group type: COMPARATOR
Intervention: Iv glipizide followed 60 min later by oral glucose
Number of subjects: 6
Study 31928269 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital fetal scalp stimulation (dFSS)
Number of subjects: 66
Study 31928269 — intervention group
Group type: COMPARATOR
Intervention: Fetal blood sampling (FBS)
Number of subjects: 66
Study 31708447 — intervention group
Group type: EXPERIMENTAL
Intervention: Support programme in addition to conventional care
Number of subjects: 2098
Study 31708447 — intervention group
Group type: COMPARATOR
Intervention: Conventional care alone
Number of subjects: 2098
Study 30226796 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release carbidopa-levodopa (CD-LD) product
Number of subjects: 0
Study 30226796 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release carbidopa-levodopa (CD-LD) product
Number of subjects: 0
Study 29411721 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal tea mixture (stinging nettle) for 1 week
Number of subjects: 85
Study 29411721 — intervention group
Group type: COMPARATOR
Intervention: Fruit tea (placebo) for 1 week
Number of subjects: 85
Study 29411721 — intervention group
Group type: COMPARATOR
Intervention: Control group (supportive measures only)
Number of subjects: 85
Study 29411721 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum prolactin levels measured at the beginning and on the seventh day
Number of subjects: 85
Study 29411721 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain of preterm babies
Number of subjects: 85
Study 26977864 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler‐assisted dearterialization of internal hemorrhoids with mucopexy (DDM)
Number of subjects: 240
Study 26977864 — intervention group
Group type: COMPARATOR
Intervention: Hemorrhoidectomy using harmonic scalpel (HE)
Number of subjects: 240
Study 25169642 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg single dose)
Number of subjects: 40
Study 25169642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 22896670 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin-fenofibric acid therapy (FNA)
Number of subjects: 1865
Study 20668372 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 ml black tea extract (BTE) daily for weeks 1-4 (increasing to 600 ml by week 4)
Number of subjects: 46
Study 20668372 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 ml black tea extract (BTE) daily
Number of subjects: 46
Study 20668372 — intervention group
Group type: COMPARATOR
Intervention: 150 ml black tea extract (BTE) daily (control group)
Number of subjects: 46
Study 16822619 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-assessment tool
Number of subjects: 343
Study 15386785 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention with reduced intake of fat and increased intakes of fiber, calcium, and vegetables and fruit, with diet counseling provided by telephone.
Number of subjects: 77
Study 15386785 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 77
Study 11876809 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal falciparum malaria infection
Number of subjects: 995
Study 11876809 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological evidence of past placental malaria infection
Number of subjects: 995
Study 10418851 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 10418851 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 0
Study 10418851 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of Metformin and Troglitazone
Number of subjects: 0
Study 7587908 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple injection regimen of insulin therapy (Group II, n = 9)
Number of subjects: 18
Study 7587908 — intervention group
Group type: COMPARATOR
Intervention: Maximal OAD (Group I, n = 9)
Number of subjects: 18
Study 29101711 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-week group-based weight loss intervention including caloric restriction and physical activity
Number of subjects: 60
Study 29101711 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-week group-based weight loss intervention
Number of subjects: 60
Study 29101711 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control intervention
Number of subjects: 60
Study 28876473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools introducing recycled materials and risk-reframing workshops
Number of subjects: 226
Study 28876473 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 226
Study 25716487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use disorder (CUD) group, N=21
Number of subjects: 35
Study 25716487 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-CUD group, N=14
Number of subjects: 35
Study 25716487 — intervention group
Group type: EXPERIMENTAL
Intervention: CUD group, N=21
Number of subjects: 35
Study 25716487 — intervention group
Group type: COMPARATOR
Intervention: Control group, N=22
Number of subjects: 35
Study 23685450 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week interactive, parent-based intervention
Number of subjects: 73
Study 23685450 — intervention group
Group type: COMPARATOR
Intervention: General health condition (control)
Number of subjects: 73
Study 22616205 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of 8 weekly sessions with interactive materials, cooking demonstrations, and discussions on breast cancer prevention.
Number of subjects: 119
Study 22616205 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of 8 weekly sessions.
Number of subjects: 119
Study 22616205 — intervention group
Group type: COMPARATOR
Intervention: Written breast health educational materials.
Number of subjects: 119
Study 19797937 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg controlled-release oxycodone
Number of subjects: 54
Study 19797937 — intervention group
Group type: COMPARATOR
Intervention: 200 mg controlled-release tramadol
Number of subjects: 54
Study 17023289 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 320
Study 17023289 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 320
Study 17023289 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 320
Study 15571784 — intervention group
Group type: EXPERIMENTAL
Intervention: DVPX+Risp
Number of subjects: 37
Study 15571784 — intervention group
Group type: EXPERIMENTAL
Intervention: Li+Risp
Number of subjects: 37
Study 10898540 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 60 mg/m2 followed by CPT‐11 190 mg/m2 on day 1, repeated every 3 weeks
Number of subjects: 15
Study 9243561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair testing for drugs of abuse (cocaine and opiates)
Number of subjects: 100
Study 9243561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair testing for drugs of abuse
Number of subjects: 100
Study 9243561 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of hair washes and nails from autopsy samples
Number of subjects: 100
Study 8438659 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly exercise
Number of subjects: 49
Study 8438659 — intervention group
Group type: COMPARATOR
Intervention: Reminiscence sessions
Number of subjects: 49
Study 3940518 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 12
Study 3940518 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral meclizine
Number of subjects: 12
Study 3940518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31227386 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender transformative life-skills education cum sports-coaching program for younger boys (aged 13-14 years)
Number of subjects: 962
Study 31605442 — intervention group
Group type: COMPARATOR
Intervention: Antioxidants
Number of subjects: 119
Study 31605442 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (systemic form)
Number of subjects: 119
Study 31605442 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (systemic and topical forms)
Number of subjects: 119
Study 28468653 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose aspirin (81 mg) daily administration, initiated between 6 0/7 weeks and 13 6/7 weeks GA and continued to 36 0/7 weeks GA
Number of subjects: 0
Study 28468653 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical appearing)
Number of subjects: 0
Study 28468653 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose aspirin (81 mg)
Number of subjects: 0
Study 25246609 — intervention group
Group type: EXPERIMENTAL
Intervention: mCIMT combined with trunk restraint
Number of subjects: 18
Study 25246609 — intervention group
Group type: COMPARATOR
Intervention: mCIMT
Number of subjects: 18
Study 22751026 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics after ED care
Number of subjects: 244
Study 21802381 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiodol transarterial chemoembolisation with amiodarone and anthracycline (pirarubicin or doxorubicin)
Number of subjects: 27
Study 21802381 — intervention group
Group type: COMPARATOR
Intervention: Lipiodol transarterial chemoembolisation with anthracycline alone (control group)
Number of subjects: 27
Study 18642348 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin-alpha
Number of subjects: 1558
Study 16801652 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective stenting of symptomatic intracranial stenosis
Number of subjects: 169
Study 14594779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group (dietary and antismoking advice)
Number of subjects: 1232
Study 14594779 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1232
Study 10764853 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted in situ keratomileusis
Number of subjects: 13
Study 9216145 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical heart valve implantation
Number of subjects: 40
Study 9216145 — intervention group
Group type: COMPARATOR
Intervention: Native mitral or aortic valves
Number of subjects: 40
Study 1598953 — intervention group
Group type: EXPERIMENTAL
Intervention: lodoxamide 0.1% ophthalmic solution
Number of subjects: 120
Study 1598953 — intervention group
Group type: COMPARATOR
Intervention: cromolyn sodium 4% ophthalmic solution
Number of subjects: 120
Study 4044294 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg riboflavin supplementation
Number of subjects: 36
Study 4044294 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg riboflavin supplementation
Number of subjects: 36
Study 4044294 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg riboflavin supplementation
Number of subjects: 36
Study 4044294 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg riboflavin load
Number of subjects: 36
Study 4044294 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplement)
Number of subjects: 36
Study 29530035 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol in group format
Number of subjects: 220
Study 29530035 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (individual cognitive behavioral therapy)
Number of subjects: 220
Study 27436422 — intervention group
Group type: EXPERIMENTAL
Intervention: Measles Vaccine (MV)
Number of subjects: 302
Study 27436422 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria-Tetanus-Pertussis (DTP)
Number of subjects: 302
Study 27436422 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MV and DTP administered together
Number of subjects: 302
Study 26420196 — intervention group
Group type: EXPERIMENTAL
Intervention: Public dietitian-led intervention
Number of subjects: 117
Study 26420196 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 117
Study 24282383 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Qigong (TCQ)
Number of subjects: 206
Study 24282383 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 206
Study 24282383 — intervention group
Group type: COMPARATOR
Intervention: Exercise group (breathing and walking exercise)
Number of subjects: 206
Study 21068672 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically administered halofuginone
Number of subjects: 0
Study 21068672 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study 18294487 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 2521
Study 18294487 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 2521
Study 16472338 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CTTH
Number of subjects: 50
Study 16472338 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study 15709463 — intervention group
Group type: EXPERIMENTAL
Intervention: Triticum vulgaris (Fitostimoline)
Number of subjects: 270
Study 15709463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 11213274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (VIAGRA)
Number of subjects: 482
Study 11213274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 482
Study 9446004 — intervention group
Group type: EXPERIMENTAL
Intervention: L-methionine (Acimethin) 3 x 1 tablet daily for 26 months
Number of subjects: 43
Study 9446004 — intervention group
Group type: COMPARATOR
Intervention: Nalidixic acid (Nevigramon) 1 tablet 3 times daily for 21.6 months
Number of subjects: 43
Study 7939490 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects under time pressure
Number of subjects: 0
Study 7939490 — intervention group
Group type: COMPARATOR
Intervention: Subjects under no time pressure
Number of subjects: 0
Study 2963213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin (800 micrograms per day)
Number of subjects: 213
Study 2963213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin (400 micrograms per day)
Number of subjects: 213
Study 2963213 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (800 mg per day)
Number of subjects: 213
Study 2963213 — intervention group
Group type: COMPARATOR
Intervention: Nafarelin (both doses) and Danazol
Number of subjects: 213
Study 2963213 — intervention group
Group type: COMPARATOR
Intervention: Nafarelin and Danazol
Number of subjects: 213
Study 2963213 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 213
Study 2963213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 213
Study 31771940 — intervention group
Group type: EXPERIMENTAL
Intervention: PEITC (10 mg in 1 mL of olive oil, 4 times per day)
Number of subjects: 79
Study 31771940 — intervention group
Group type: COMPARATOR
Intervention: PEITC
Number of subjects: 79
Study 29288162 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (nHF)
Number of subjects: 429
Study 29288162 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (CPAP)
Number of subjects: 429
Study 27916036 — intervention group
Group type: COMPARATOR
Intervention: Patient Controlled Intravenous Analgesia (PCIA)
Number of subjects: 60
Study 27916036 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Controlled Thoracic Paravertebral Block (PCPB)
Number of subjects: 60
Study 24325649 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel disposable sheathed gastroscope
Number of subjects: 1140
Study 24325649 — intervention group
Group type: COMPARATOR
Intervention: Conventional gastroscope
Number of subjects: 1140
Study 22728645 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach Avoidance Task (AAT) designed to increase approach tendencies for positive social cues
Number of subjects: 0
Study 22728645 — intervention group
Group type: COMPARATOR
Intervention: Control condition with no contingency between arm movement direction and picture type
Number of subjects: 0
Study 20386017 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotrastaurin 400 mg
Number of subjects: 18
Study 20386017 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 7 mg
Number of subjects: 18
Study 20386017 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotrastaurin 400 mg + Tacrolimus 7 mg
Number of subjects: 18
Study 18175741 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh yogurt
Number of subjects: 79
Study 18175741 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated yogurt
Number of subjects: 79
Study 18175741 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yogurt)
Number of subjects: 79
Study 15753744 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support on (smart infusion pumps with integrated decision support software)
Number of subjects: 744
Study 15753744 — intervention group
Group type: COMPARATOR
Intervention: Decision support off (control group)
Number of subjects: 744
Study 14523142 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine
Number of subjects: 39936
Study 10590328 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined vaccine
Number of subjects: 150
Study 10590328 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous vaccination
Number of subjects: 150